Levi & Korsinsky, LLP is investigating Bio-Rad Laboratories, Inc.
(“Bio-Rad” or the “Company”) (NYSE:BIO) in connection with possible
breaches of fiduciary duty by the Board of Directors of the Company.
To get more information, click here: http://zlk.9nl.com/bio-rad-laboratories-bio.
There is no cost or obligation to you.
On November 3, 2014, the Company announced the resolution of
previously-disclosed investigations by the Department of Justice and
Securites and Exchange Commission, concerning past violations of the
Foreign Corrupt Practices Act between 2005 and 2010. Bio-Rad has agreed
to pay a penalty of $14.35 million, and under the terms of a civil
settlement with the SEC, the Company will also pay $40.7 million in
disgorgement and prejudgment interest.
If you own common stock in Bio-Rad and wish to obtain additional
information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/bio-rad-laboratories-bio.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm’s attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
Copyright Business Wire 2014